Research Articles | Page 86 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Reduced ribosomal RNA expression and increased ribosomal DNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes Oct 2012 Blood myelodysplastic syndromes (MDS)
Stem and progenitor cell alterations in myelodysplastic syndromes Feb 2017 Blood myelodysplastic syndromes (MDS)
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations. Jul 2012 Blood myelodysplastic syndromes (MDS)
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Sep 2014 Blood aplastic anemia
Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70 Nov 2016 Blood aplastic anemia
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry. Feb 2012 Biomark Med paroxysmal nocturnal hemoglobinuria (PNH)
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease Jan 2018 Biology of Blood and Marrow Transportation graft versus host disease (GVHD)
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia May 2019 Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation aplastic anemia
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia Dec 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation aplastic anemia
Share with addtoany.com.